Who Supplies Fluoxetine? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Fluoxetine exports, with 253+ registered manufacturers shipping to buyers across 101+ countries — yet a handful of companies dominate the shipments. SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED holds the largest share at 48.2% (export value: $113.3M). Close behind, INTAS PHARMACEUTICALS LIMITED (12.0%, $28.2M). MICRO LABS LIMITED (8.8%, $20.8M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Fluoxetine? Top Manufacturers & Their Buyers
Flow of Fluoxetine from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Fluoxetine Supplier Network — Key Market Intelligence
The Fluoxetine export market from India is led by SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED, which alone commands a 48.2% share, shipping $113.3M worth of product across 99 shipments. The second-largest exporter, INTAS PHARMACEUTICALS LIMITED, contributes $28.2M (12.0%) to the overall market. Combined, the top two suppliers alone account for 60.2% of all Fluoxetine exports, indicating a relatively concentrated supply base.
Across all 253 tracked manufacturers, the total Fluoxetine export value stands at $235.3M from 3.7K shipments. The market average shipment value is $63.6K. The single largest buyer relationship in terms of trade value is AVET PHARMACEUTICALS INC C/O, receiving $112.8M worth of product.
The combined buyer network spans 16 named purchasing companies, including AVET PHARMACEUTICALS INC C/O, ACCORD HEALTHCARE INC.,, JAMP PHARMA CORPORAT, BROWN AND BURK LIMITED, IMRES B.V. and 11 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED
SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED is the first-largest Fluoxetine exporter from India, with a market share of 48.2% and a total export value of $113.3M across 99 shipments. Their average shipment value of $1.1M is above the market average of $63.6K, suggesting premium or bulk contract pricing.
SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED serves 4 named buyers in our database. AVET PHARMACEUTICALS INC C/O is the dominant customer, accounting for 99.5% of this supplier's tracked business. Top customers include:
• AVET PHARMACEUTICALS INC C/O — $112.8M across 99 shipments (99.5% of this supplier's total exports)
• AVET PHARMACEUTICALS INC C/O — $268.0K across 0 shipments (0.2% of this supplier's total exports)
• AVET PHARMACEUTICALS INC C/O — $123.4K across 0 shipments (0.1% of this supplier's total exports)
• AVET PHARMACEUTICALS INC C/O — $121.9K across 0 shipments (0.1% of this supplier's total exports)
Key Insight: SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED's per-shipment value of $1.1M is 1701% above the market average of $63.6K, consistent with large-order contracts or value-added formulations.
2INTAS PHARMACEUTICALS LIMITED
INTAS PHARMACEUTICALS LIMITED is the second-largest Fluoxetine exporter from India, with a market share of 12.0% and a total export value of $28.2M across 97 shipments. Their average shipment value of $290.7K is above the market average of $63.6K, suggesting premium or bulk contract pricing.
INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. ACCORD HEALTHCARE INC., is the dominant customer, accounting for 90.1% of this supplier's tracked business. Top customers include:
• ACCORD HEALTHCARE INC., — $25.4M across 87 shipments (90.1% of this supplier's total exports)
• ACCORD HEALTHCARE INC., — $2.4M across 8 shipments (8.6% of this supplier's total exports)
• ACCORD HEALTHCARE INC., — $197.7K across 1 shipments (0.7% of this supplier's total exports)
• JAMP PHARMA CORPORAT — $127.0K across 0 shipments (0.5% of this supplier's total exports)
• ACCORD HEALTHCARE INC., — $58.8K across 0 shipments (0.2% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED's per-shipment value of $290.7K is 357% above the market average of $63.6K, consistent with large-order contracts or value-added formulations.
3MICRO LABS LIMITED
MICRO LABS LIMITED is the third-largest Fluoxetine exporter from India, with a market share of 8.8% and a total export value of $20.8M across 154 shipments. Their average shipment value of $135.1K is above the market average of $63.6K, suggesting premium or bulk contract pricing.
MICRO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• BROWN AND BURK LIMITED — $10.4M across 77 shipments (50.0% of this supplier's total exports)
• IMRES B.V. — $8.8M across 65 shipments (42.1% of this supplier's total exports)
• TEVA 3PL WAREHOUSE ( — $751.7K across 6 shipments (3.6% of this supplier's total exports)
• IMPERIAL MEDICAL SOL — $482.1K across 4 shipments (2.3% of this supplier's total exports)
• ARROW PHARMACEUTICAL — $420.7K across 3 shipments (2.0% of this supplier's total exports)
Key Insight: MICRO LABS LIMITED's per-shipment value of $135.1K is 113% above the market average of $63.6K, consistent with large-order contracts or value-added formulations.
4AUROBINDO PHARMA LTD
AUROBINDO PHARMA LTD is the fourth-largest Fluoxetine exporter from India, with a market share of 3.2% and a total export value of $7.6M across 232 shipments. Their average shipment value of $32.9K is below the market average of $63.6K, reflecting a high-volume, competitive pricing strategy.
AUROBINDO PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• ORION CORPORATION, — $3.0M across 92 shipments (39.6% of this supplier's total exports)
• APL SWIFT SERVICES (MALTA) LTD., — $1.9M across 58 shipments (25.1% of this supplier's total exports)
• AUROLOGISTICS LLC (AUROBINDO PHARMA — $1.2M across 36 shipments (15.5% of this supplier's total exports)
• AUROLOGISTICS LLC (AUROBINDO PHARMA — $855.2K across 26 shipments (11.2% of this supplier's total exports)
• AUROLOGISTICS LLC, ( — $658.5K across 20 shipments (8.6% of this supplier's total exports)
Key Insight: AUROBINDO PHARMA LTD operates with high shipment frequency (232 shipments) at a per-shipment value of $32.9K, indicating a broad distribution network with many smaller, regular orders.
5TORRENT PHARMACEUTICALS LTD
TORRENT PHARMACEUTICALS LTD is the fifth-largest Fluoxetine exporter from India, with a market share of 2.0% and a total export value of $4.6M across 39 shipments. Their average shipment value of $119.2K is above the market average of $63.6K, suggesting premium or bulk contract pricing.
TORRENT PHARMACEUTICALS LTD serves 4 named buyers in our database. TORRENT PHARMA INC, is the dominant customer, accounting for 91.2% of this supplier's tracked business. Top customers include:
• TORRENT PHARMA INC, — $4.2M across 36 shipments (91.2% of this supplier's total exports)
• TORRENT PHARMA INC, — $405.3K across 3 shipments (8.7% of this supplier's total exports)
• PHARMACEUTICAL AND C — $4.7K across 0 shipments (0.1% of this supplier's total exports)
• PHARMACEUTICAL AND C — $975 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: TORRENT PHARMACEUTICALS LTD's per-shipment value of $119.2K is 88% above the market average of $63.6K, consistent with large-order contracts or value-added formulations.
6ALEMBIC PHARMACEUTICALS LIMITED
ALEMBIC PHARMACEUTICALS LIMITED is the fifth-largest Fluoxetine exporter from India, with a market share of 1.6% and a total export value of $3.8M across 261 shipments. Their average shipment value of $14.6K is below the market average of $63.6K, reflecting a high-volume, competitive pricing strategy.
ALEMBIC PHARMACEUTICALS LIMITED serves 5 named buyers in our database. J. KNIPPER & COMPANY is the dominant customer, accounting for 52.4% of this supplier's tracked business. Top customers include:
• J. KNIPPER & COMPANY — $2.0M across 137 shipments (52.4% of this supplier's total exports)
• J. KNIPPER & COMPANY — $980.4K across 67 shipments (25.7% of this supplier's total exports)
• J. KNIPPER & COMPANY — $342.9K across 24 shipments (9.0% of this supplier's total exports)
• J. KNIPPER & COMPANY — $303.0K across 21 shipments (8.0% of this supplier's total exports)
• MINT PHARMACEUTICAL — $186.6K across 13 shipments (4.9% of this supplier's total exports)
Key Insight: ALEMBIC PHARMACEUTICALS LIMITED operates with high shipment frequency (261 shipments) at a per-shipment value of $14.6K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Fluoxetine Flows
Once Fluoxetine leaves the manufacturing plants of companies like SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED and INTAS PHARMACEUTICALS LIMITED, it travels to 5 destination markets with a combined import value of $235.3M. United States absorbs the largest share at 65.6% ($154.4M), followed by Canada (12.9%) and United Kingdom (8.1%).
In United States — the top destination — named importers include AVET PHARMACEUTICALS INC C/O, TORRENT PHARMA INC,, TIME-CAP LABS,. In Canada, key buyers are ACCORD HEALTHCARE INC,, ACCORD HEALTHCARE INC.,.
This geographic spread reflects Fluoxetine's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Fluoxetine Go? Top Importing Countries & Their Buyers
Trade flow of Fluoxetine exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Fluoxetine imports from India, with a total trade value of $154.4M across 389 shipments — representing a 65.6% share of all Fluoxetine exports. The average shipment value of $397.0K is above the global average of $63.6K, indicating high-value procurement contracts or branded formulations. This market is served by 10 tracked buyers.
Named Fluoxetine importers in United States: AVET PHARMACEUTICALS INC C/O is the largest buyer, accounting for 73.1% ($112.8M) of this market's total imports.
• AVET PHARMACEUTICALS INC C/O — $112.8M (73.1% of United States's total)
• TORRENT PHARMA INC, — $7.9M (5.1% of United States's total)
• TIME-CAP LABS, — $2.7M (1.7% of United States's total)
Key Insight: United States's per-shipment average of $397.0K (525% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Fluoxetine imports from India.
2Canada
Canada ranks as the second-largest destination for Fluoxetine imports from India, with a total trade value of $30.3M across 16 shipments — representing a 12.9% share of all Fluoxetine exports. The average shipment value of $1.9M is above the global average of $63.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Fluoxetine importers in Canada: ACCORD HEALTHCARE INC, is the largest buyer, accounting for 83.7% ($25.4M) of this market's total imports.
• ACCORD HEALTHCARE INC, — $25.4M (83.7% of Canada's total)
• ACCORD HEALTHCARE INC., — $2.7M (9.1% of Canada's total)
Key Insight: Canada's per-shipment average of $1.9M (2883% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Fluoxetine imports from India.
3United Kingdom
United Kingdom ranks as the third-largest destination for Fluoxetine imports from India, with a total trade value of $19.2M across 137 shipments — representing a 8.1% share of all Fluoxetine exports. The average shipment value of $140.0K is above the global average of $63.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Fluoxetine importers in United Kingdom: BROWN AND BURK LIMITED is the largest buyer, accounting for 55.2% ($10.6M) of this market's total imports.
• BROWN AND BURK LIMITED — $10.6M (55.2% of United Kingdom's total)
• MEDREICH PLC — $2.2M (11.4% of United Kingdom's total)
Key Insight: United Kingdom's per-shipment average of $140.0K (120% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Kingdom is a key market for Fluoxetine imports from India.
4Netherlands
Netherlands ranks as the fourth-largest destination for Fluoxetine imports from India, with a total trade value of $9.3M across 7 shipments — representing a 3.9% share of all Fluoxetine exports. The average shipment value of $1.3M is above the global average of $63.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Fluoxetine importers in Netherlands: IMRES B.V. is the largest buyer, accounting for 95.2% ($8.8M) of this market's total imports.
• IMRES B.V. — $8.8M (95.2% of Netherlands's total)
Key Insight: Netherlands's per-shipment average of $1.3M (1980% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Netherlands is a key market for Fluoxetine imports from India.
5South Africa
South Africa ranks as the fifth-largest destination for Fluoxetine imports from India, with a total trade value of $3.8M across 0 shipments — representing a 1.6% share of all Fluoxetine exports. The average shipment value of $3.8M is above the global average of $63.6K, indicating high-value procurement contracts or branded formulations.
Key Insight: South Africa's per-shipment average of $3.8M (5818% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
South Africa is a key market for Fluoxetine imports from India.
People Also Ask — Fluoxetine Supplier & Trade Network
Who are the top suppliers of Fluoxetine from India?+
Which companies buy Fluoxetine from Indian manufacturers?+
Where does Fluoxetine exported from India go?+
What is the market share of the top Fluoxetine supplier from India?+
What is the average shipment value for Fluoxetine exports from India?+
Is Fluoxetine manufactured in India and exported globally?+
Which country imports the most Fluoxetine from India?+
Who are the buyers of Fluoxetine in Canada?+
How concentrated is the Fluoxetine supplier market in India?+
How do I find verified buyers for Fluoxetine in specific countries?+
Fluoxetine Trade Network — Key Takeaways
- 1SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED is India's dominant Fluoxetine exporter with a 48.2% market share and $113.3M in total exports — making it the single most important sourcing entity in this market.
- 2The top 253 suppliers collectively account for 75.8% of all tracked Fluoxetine exports, with a combined trade value of $235.3M.
- 3United States is the largest destination market, absorbing 65.6% of India's Fluoxetine exports ($154.4M). Canada (12.9%) and United Kingdom (8.1%) follow.
- 4With 3.7K total shipments averaging $63.6K each, the Fluoxetine export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include AVET PHARMACEUTICALS INC C/O, AVET PHARMACEUTICALS INC C/O, ACCORD HEALTHCARE INC.,, ACCORD HEALTHCARE INC., — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 4 customers
6 suppliers → 101 countries
Network value: $235.3M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Fluoxetine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Fluoxetine.
- 2.Flow Mapping: 253 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,702 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 101 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,702 Verified Shipments
253 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists